Galactosidase beta 1 like 3 (GLB1L3)

Galactosidase beta 1 like 3 (GLB1L3) is a protein-coding gene that encodes a probable glycosyl hydrolase enzyme, predicted to have beta-galactosidase activity and to participate in the catabolic process of galactose[7]. GLB1L3 is believed to be located in the vacuole and extracellular region, functioning in hydrolyzing O-glycosyl compounds[7]. Although closely related to other beta-galactosidase and glycosidase family members, the clinical roles and specific substrates of GLB1L3 remain undercharacterized. Diseases associated with GLB1L3 include spherocytosis, type 4 and mucopolysaccharidosis, type IVB, although the precise pathogenic mechanisms are unclear and further validation is needed[7]. No drugs are currently known to target GLB1L3 specifically, nor is it a validated therapeutic target at present.

Other names

Beta-galactosidase-1-like protein 3FLJ90231GLB1L3beta-galactosidase-1-like protein 34921509F24Rik[4][7]